COSTECH

Chinese Researchers Rising Stars in Regenerative Medicine Despite
Global Skepticism of Stem Cell Therapies

The McLaughlin-Rotman Centre for Global Health is pleased to announce
the publication of the article, “Cultivating regenerative medicine
innovation in China” in the current (January 2010) issue of the
journal Regenerative Medicine. This research outlines the current
research and development in regenerative medicine in China, including
its main strength and weaknesses. This project is supported by the
Canadian Institutes of Health Research.

Please click the following link for full access to the article:
http://cts.vresp.com/c/?McLaughlinRotmanCent/b71122eb42/9a4c6f8aa6/7a6c101676


McMahon DS, Thorsteinsdóttir H, Singer PA, Daar AS: Cultivating
regenerative medicine innovation in China. Regen. Med. 5(1), 35–44
(2010)

While China has become a significant contributor and prolific
publisher in regenerative medicine, its role in the field is not well
understood. We analyzed how capacity in regenerative medicine was
built in China to identify some of its main strengths and challenges.
This case study of regenerative medicine in China was primarily based
on interviews with almost 50 Chinese researchers, policy makers,
clinicians, company executives and regulators. Our analysis shows
China’s government is pouring dollars generously into regenerative
medicine (RM) research and aggressively recruiting high-caliber
scientists trained abroad in pursuit of its ambition to become a world
leader in the field. Chinese contributions to scientific journals on
RM topics leapt from 37 in year 2000 to 1,116 in 2008, exceeded only
by the contributions of experts in four other countries: the USA,
Germany, Japan and the UK. The accomplishment is all the more
astonishing given that China’s international credibility has been
hindered by global concerns surrounding Chinese stem cell clinics that
have made unproven therapies available. If China continues to build on
its strengths and overcomes its challenges, internationally recognized
Chinese regenerative medicine treatments and therapies are likely to
be a future reality.

For further information please contact Halla Thorsteinsdóttir at:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it